NCT00040911

Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma

A Randomized Study Of Electroacupuncture Treatment For Delayed Chemotherapy-Induced Nausea And Vomiting In Patients With Pediatric Solid Tumors

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 17 (actual)
• Sponsor: Children's Oncology Group · Network
• Sex: All
• Age: 5 Years – 35 Years
• Healthy volunteers: Not accepted

Summary

RATIONALE: Electroacupuncture may help to reduce or prevent delayed nausea and vomiting in patients treated with chemotherapy. PURPOSE: This randomized clinical trial is studying the effectiveness of electroacupuncture in treating delayed nausea and vomiting in patients who are receiving chemotherapy for newly diagnosed childhood sarcoma, neuroblastoma, nasopharyngeal cancer, germ cell tumors, or Hodgkin lymphoma.

Detailed description

OBJECTIVES: Primary * Determine the efficacy of electroacupuncture, in terms of reducing acute and delayed chemotherapy-induced nausea, in patients with newly diagnosed pediatric sarcoma, neuroblastoma, nasopharyngeal carcinoma, or germ cell tumors. Secondary * Determine the efficacy of this therapy, in terms of reducing delayed chemotherapy-induced emesis, in these patients. * Determine the efficacy of this therapy, in terms of altering salivary cortisol levels and fasting serum glucose and insulin levels as stress parameters, in these patients. * Determine the efficacy of this therapy, in terms of improving the quality of life, in these patients. * Determine the efficacy of this therapy, in terms of reducing acute nausea and emesis, in these patients. OUTLINE: This is a multicenter, randomized, double-blind study. Patients are stratified according to planned treatment with cisplatin-based chemotherapy (yes vs no) and gender. Patients are randomized to 1 of 2 arms. * Arm I: Patients undergo electroacupuncture to specific acupuncture points on the arms and legs over 25 minutes twice daily on days 1 and 2 and then once daily on days 3-7 during week 1 of chemotherapy course 1 (9 acupuncture treatments total). * Arm II: Patients undergo electroacupuncture to sham points on the arms and legs as in arm I. Quality of life is assessed at baseline, on days 1 and 8 of each treatment course, and then after completion of the study. PROJECTED ACCRUAL: A total of 65 patients (approximately 32 per arm) will be accrued for this study within 2.5-3 years.

Conditions

• Brain Tumors
• Central Nervous System Tumors
• Childhood Germ Cell Tumor
• Extragonadal Germ Cell Tumor
• Head and Neck Cancer
• Lymphoma
• Nausea
• Vomiting
• Neuroblastoma
• Ovarian Cancer
• Sarcoma

Interventions

Type	Name	Description
PROCEDURE	electroacupuncture therapy
PROCEDURE	sham intervention	Undergo electroacupuncture therapy to sham points
PROCEDURE	quality-of-life assessment	Ancillary studies

Timeline

• Start date: 2005-04-01
• Primary completion: 2009-10-01
• Completion: 2011-01-01
• First posted: 2003-01-27
• Last updated: 2013-05-31

Locations

1 site across 1 country: United States